FIELD: medicine, chemical-pharmaceutical industry.
SUBSTANCE: invention relates to an anti-coagulating, anti-thrombocytic, anti-thrombosis, fibrin-depolymerizing and fibrinolytic agent containing heptapeptide selank of the formula: Thr-Lys-Pro-Arg-Pro-Gly-Pro. The claimed agent possesses high activity and effectiveness as compared with the known agents.
EFFECT: enhanced medicinal properties of agent.
2 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PEPTIDE POSSESSING ANTICOAGULANT, FIBRIN-DEPOLYMERIZING, ANTI-THROMBOSIS AND FIBRINOLYTIC ACTIVITIES | 2005 |
|
RU2289423C1 |
| PEPTIDE POSSESSING ANTI-COAGULANT, FIBRIN-DEPOLYMERIZATION, ANTI-THROMBOSIS AND FIBRINOLYTIC ACTIVITIES | 2005 |
|
RU2288736C1 |
| ANTI-THROMBOSIS, ANTI-COAGULATING, FIFRIN-DEPOLYMERIZING AND FIBRINOLYTIC AGENT FOR INTRANASAL ADMINISTRATION | 2005 |
|
RU2290193C1 |
| ANTI-THROMBOSIS, ANTI-COAGULATING, FIBRIN-DEPOLYMERIZING AND FIBRINOLYTIC AGENT | 2005 |
|
RU2290194C1 |
| ANTI-THROMBOSIS, ANTICOAGULANT, FIBRIN DEPOLYMERIZING, FIBRINOLYTIC AGENT FOR INTRAVENOUS ADMINISTRATION | 2005 |
|
RU2286168C1 |
| PEPTIDES WITH ANTICOAGULANT, FIBRINOLYTIC, ANTI-PLATELET AND ANTI-THROMBOSIS ACTIVITY | 2005 |
|
RU2286166C1 |
| ANTI-THROMBOSIS, ANTI-COAGULANT, FIBRIN-DEPOLYMERIZATION, FIBRINOLYTIC AGENT FOR INTRAMUSCULAR ADMINISTRATION | 2005 |
|
RU2288737C1 |
| USING TETRAPEPTIDE Arg-Pro-Gly-Pro AS AGENT FOR PREVENTING AND TREATING HYPERCHOLESTEREMIA, METHOD FOR PREVENTING AND TREATING HYPERCHOLESTEREMIA, PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING HYPERCHOLESTEREMIA AND METHOD FOR PREPARING IT | 2013 |
|
RU2538801C2 |
| METHOD OF TREATING DIABETES IN ANIMALS | 2009 |
|
RU2403910C1 |
| APPLICATION OF Pro-Gly-Pro-Leu TETRAPEPTIDE AS AGENT FOR PREVENTION AND TREATMENT OF DIABETES, METHOD FOR PREVENTION AND TREATMENT OF DIABETES AND PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF DIABETES | 2008 |
|
RU2378005C1 |
